Search

everythinglearnresearchcommunity

for

Search:↓

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

TNF-alpha inhibitors can cause various immune-related skin issues.

UV light helped human hair transplants survive in mice without broad immunosuppression.

A new form of lipodystrophy in HIV patients causes neck fat buildup.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

The woman has Discoid Lupus Erythematosus and needs specialist care.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Injectable hyaluronic acid can effectively treat facial lipoatrophy from lupus panniculitis.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

Natural killer cells play a key role in autoimmune skin diseases like pemphigus vulgaris.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Injectable platelet-rich fibrin may stop hair loss from Discoid lupus erythematosus.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Dupilumab can cause lupus-like symptoms, so patients need careful monitoring.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Type I interferons may help treat skin issues in lupus and dermatomyositis.

The albumin change rate helps predict treatment success in AIDS-related non-Hodgkin lymphoma.